New combo therapy aims to stop limited cancer spread in its tracks
Disease control
Not yet recruiting
This study is testing whether combining a precise, high-dose radiation treatment (SBRT) with a new targeted drug (vibecotamab) can better control cancer that has spread to a few sites in the body. It is for adults with EGFR-positive solid tumors that have spread to 5 or fewer loc…
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC